Risk Assessment of Tuberculosis in Contacts by IFN-γ Release Assays. A Tuberculosis Network European Trials Group Study. - Wikidata - wikimedia - TriplyDB

Risk Assessment of Tuberculosis in Contacts by IFN-γ Release Assays. A Tuberculosis Network European Trials Group Study.

Risk Assessment of Tuberculosis in Contacts by IFN-γ Release Assays. A Tuberculosis Network European Trials Group Study.

http://www.wikidata.org/entity/Q41436229

about

Correlates of tuberculosis risk: predictive biomarkers for progression to active tuberculosis Update in Tuberculosis/Pulmonary Infections 2015 Update in Mycobacterium tuberculosis lung disease 2014.Risk of Tuberculosis Reactivation in Patients with Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Receiving Non-Anti-TNF-Targeted Biologics Risk for latent and active tuberculosis in Germany.Different Risk of Tuberculosis and Efficacy of Isoniazid Prophylaxis in Rheumatoid Arthritis Patients with Biologic Therapy: A Nationwide Retrospective Cohort Study in Taiwan Tuberculosis progression rates in U.S. Immigrants following screening with interferon-gamma release assays.Clinical Application of Interferon-γ Release Assays for the Prevention of Tuberculosis in Countries with Low Incidence.Assessment of the influence of direct tobacco smoke on infection and active TB management.Evaluating 17 years of latent tuberculosis infection screening in north-west England: a retrospective cohort study of reactivation.Optimization and Interpretation of Serial QuantiFERON Testing to Measure Acquisition of Mycobacterium tuberculosis Infection.New tests for detection of Mycobacterium tuberculosis infection: sufficient to meet the WHO 2035 targets?An evaluation of tuberculosis contact investigations against national standards.Prognostic value of interferon-γ release assays, a population-based study from a TB low-incidence country.Lipoarabinomannan-Responsive Polycytotoxic T Cells Are Associated with Protection in Human Tuberculosis.QuantiFERON®-TB Gold In-Tube for contact screening in BCG-vaccinated adults: A longitudinal cohort study.Exposed, but Not Protected: More Is Needed to Prevent Drug-Resistant Tuberculosis in Healthcare Workers and Students.The Tuberculosis Network European Trials Group (TBNET): new directions in the management of tuberculosis.Mycobacterium kansasii Pneumonia with Mediastinal Lymphadenitis in a Patient with Acute Myeloid Leukemia: Successful Treatment to Stem Cell Transplantation.Pulmonary immune responses to Mycobacterium tuberculosis in exposed individuals.Evaluating UK National Guidance for Screening of Children for TB: A Prospective Multi-centre Study.From latent to active TB: are IGRAs of any use?Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children.Early clearance versus control: what is the meaning of a negative tuberculin skin test or interferon-gamma release assay following exposure to Mycobacterium tuberculosis?IFN-γ Release Assays for Risk Assessment in Contacts of Patients with Tuberculosis in Low-Burden European Countries Recommendations for the screening of paediatric latent tuberculosis infection in indigenous communities: a systematic review of screening strategies among high-risk groups in low-incidence countries

P2860

Q28077155-8130118D-A6B3-4970-BE1D-830D8C004CC6 Q28387739-43437F5B-390A-4FCF-AAC2-22E7BE8F5213 Q33735642-2C21FF70-5FB5-4F82-98E1-52CA21DEF7F7 Q33809045-26F98306-FEC3-4081-AEC9-4FD50A93C833 Q33845283-E1554251-4981-48E9-875D-A78526BC109E Q35985497-D44CA255-8418-4E68-9ED7-F247400B608F Q36112266-F03F1384-1B9D-451C-9AA0-A710008C1D08 Q37649784-4BE25992-14D3-4154-8CFC-AB3A87CB0EDD Q38610122-3DA4B3AE-44C9-4C62-B2EE-A7526D6F8AEB Q38656624-9FE7E027-8F5B-4E87-88C7-F21982E9F5EF Q38664922-4DD4C810-EAF6-4D50-917B-D4B399E51FDB Q38829376-73066D1A-415D-4213-A87D-A010A67A7967 Q38847143-DAA0046B-808C-4FE4-AF2D-E267E372B4D4 Q39875966-961955D3-DB49-4B88-A7F6-14169191C48D Q39993507-9E58B3D9-3CC6-4F6C-816C-FE63D4202F17 Q40074673-3D67F0ED-A15C-415A-8664-7FFE663DBD0A Q40697219-FE3EB6D4-E574-46A4-BFDE-A99B6EDBBED1 Q41683618-043669AB-6104-451B-80D5-D9D514A350A4 Q42366350-61EEABFA-D957-4734-B5D9-6601F8B95C30 Q45544527-8DF74C52-F19F-417D-AA6D-EA3C9420440C Q47203729-B7E3ED16-19AD-448F-8497-FEAEF0E66FCD Q51291459-E1D354FC-AB5A-4C8C-85A6-78537EE57993 Q53641549-C5F4D451-8DBB-4DB0-AC99-FF23E4943074 Q55097452-3650FCD1-61EA-4338-89EA-7E1F8493B007 Q56394992-14B10FA0-D4FA-45A5-8276-922B7FACCD18 Q58798924-EDE5651F-C017-46D4-9939-BECB03C2E2B0

P2860

Risk Assessment of Tuberculosis in Contacts by IFN-γ Release Assays. A Tuberculosis Network European Trials Group Study.

http://www.wikidata.org/entity/Q41436229

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Risk Assessment of Tuberculosi ...... k European Trials Group Study.

@en

type

label

Risk Assessment of Tuberculosi ...... k European Trials Group Study.

@en

prefLabel

Risk Assessment of Tuberculosi ...... k European Trials Group Study.

@en

P1433

Q41436229-739A2A82-B4BD-46C8-87B7-96DE665E8AA2

P1476

Q41436229-37AC1BB0-44C6-4A4E-9AFD-605566C22D29

P2093

Q41436229-28AA7825-83D3-4E09-BC19-0F4F6DF4052A

Q41436229-318999B1-66D4-4DDF-B7A5-96A732CE0350

Q41436229-323F9EDA-6531-4C3B-804C-37BED2D057BD

Q41436229-3D19F123-E640-4E5D-8742-9906D0D171F9

Q41436229-3E702667-235F-4777-8579-BDC3A091F17B

Q41436229-48E07943-1D04-4C39-BB55-F02C4C5844DE

Q41436229-59517D90-B8B2-4D77-A605-F3FF851F223E

Q41436229-5CC97DDF-347D-49FC-8F56-7A62E1CFC562

Q41436229-71629AEB-073D-405A-872D-9D88DE967847

Q41436229-7E2E5EA3-7300-44DA-9D0D-FA21DD162329

P2860

Q41436229-1C7EE3DA-3CF2-40D3-8BCB-C9FAD900567C

Q41436229-1D86E2F9-F1F4-4628-93CA-8F0F231E7D79

Q41436229-1EE428BF-FBEA-48CD-AD83-93FE0C3611D4

Q41436229-411125C6-17DE-4303-AAFC-4ABF634C75A2

Q41436229-5F8C65A3-7F8B-4B0F-8C1C-F5415BA7E918

Q41436229-6E5E64AD-14E4-4012-B1A4-F51406AB84D0

Q41436229-7A2F4DF5-D3D1-4DB3-96AA-6CE66FD8BEDE

Q41436229-7BB7CC1E-590D-4E68-9A6A-C1B5C8DC7371

Q41436229-80492422-1303-41BA-8B69-19FE983395E6

Q41436229-82020F33-909A-4DDF-9A21-5543C320869B

P304

Q41436229-254A01A8-DE17-41AE-A9E8-6A6B0D320080

P31

Q41436229-96DEFA5B-FDB2-43A8-A33A-6A58D9103DCA

P356

Q41436229-56F5BC95-78E2-4126-90DA-D4367F0975B2

P407

Q41436229-4AF38315-4A88-445E-9E1D-B495BA297F39

P433

Q41436229-604C8C12-6E43-4025-B8BF-9378291C3E8F

P478

Q41436229-A56C386B-BD8D-4E49-89BB-70C452CABF51

P50

Q41436229-1320A99B-E674-4566-85E7-B64C818D0B60

Q41436229-34D66B51-B5A7-4CE2-9AF7-7AAF57BD94F2

Q41436229-44935D60-4951-45C0-91B8-BC5EFF4E440B

Q41436229-48952C30-3DF4-4782-BD67-67599F46196B

Q41436229-7A8F599F-CA10-49A7-9F52-3F5FC330D870

Q41436229-942A8343-14D4-406A-8B8C-F61393C11C3F

Q41436229-ACB864FF-30A2-4385-9D5A-83C2F142B9AA

Q41436229-C00CBCAD-9C6C-4FC0-A94E-9A78ECA61380

Q41436229-CEE632EA-606F-42D9-9C2A-0119E895F724

Q41436229-F895DEB9-F4D2-4F17-8725-90F95F682BD6

P577

Q41436229-E13A77CE-3D9A-41E7-8854-34387E919592

P5875

Q41436229-83E67928-A84F-44A8-A09D-4B36C8C2DE78

P698

Q41436229-0E21CD34-1547-4655-B64C-8062AAAB47A6

P921

Q41436229-FB65ACF8-F169-468D-A43B-146541A2BB33

P356

RCCM.201502-0232OC

P1433

American Journal of Respiratory and Critical Care Medicine

P1476

Risk Assessment of Tuberculosi ...... rk European Trials Group Study

@en

P2093

Asunción Seminario Ruiz

http://www.w3.org/2001/XMLSchema#string

Christina Bothe

http://www.w3.org/2001/XMLSchema#string

Delia Goletti

http://www.w3.org/2001/XMLSchema#string

Doris Hellwig

http://www.w3.org/2001/XMLSchema#string

Eveline Henninger

http://www.w3.org/2001/XMLSchema#string

Geneviève Pache

http://www.w3.org/2001/XMLSchema#string

Graham Bothamley

http://www.w3.org/2001/XMLSchema#string

Heidrun Rath

http://www.w3.org/2001/XMLSchema#string

Helga Heykes-Uden

http://www.w3.org/2001/XMLSchema#string

Isabelle Fresard

http://www.w3.org/2001/XMLSchema#string

P2860

Predictive value of interferon-γ release assays for incident active tuberculosis: a systematic review and meta-analysis

Attitudes about tuberculosis prevention in the elimination phase: a survey among physicians in Germany

Outcomes of contact investigations of infectious tuberculosis patients.

Impact of targeted testing for latent tuberculosis infection using commercially available diagnostics

Contact investigation for tuberculosis: a systematic review and meta-analysis.

Tuberculosis and latent tuberculosis infection in close contacts of people with pulmonary tuberculosis in low-income and middle-income countries: a systematic review and meta-analysis.

Challenges with QuantiFERON-TB Gold assay for large-scale, routine screening of U.S. healthcare workers.

TBNET - Collaborative research on tuberculosis in Europe.

Gamma interferon release assays for detection of Mycobacterium tuberculosis infection.

Treatment of latent infection with Mycobacterium tuberculosis: update 2010.

P304

1176-1184

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1164/RCCM.201502-0232OC

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

191

http://www.w3.org/2001/XMLSchema#string

P50

Giovanni Sotgiu

José Domínguez

Christoph Lange

José-María García-García

Felix Ringshausen

P577

2015-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

273466509

http://www.w3.org/2001/XMLSchema#string

P698

25763458

http://www.w3.org/2001/XMLSchema#string

P921

Akafuba bulwadde